RARE
Ultragenyx PharmaceuticalCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RARE vs peer average
55/100
RARE vs. peer average (C vs. C)
Grade spread
B 3 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
BMRN is the first available peer comparator.
BioMarin: established rare-disease commercial and gene-therapy experience; useful comparator.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RARE
Ultragenyx Pharmaceutical
BMRN
BioMarin Pharmaceutical
Grade
C
C
Momentum
40
26
Value
41
66
Sentiment
66
59
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs BMRN
RARE / BMRN
Grade Position
In line
RARE vs. peer average (C vs. C)
55/100
Momentum
40
RAREValue
41
BMRNSentiment
66
RARERotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RARE
BMRN is the first peer returned for this comparison set.